Donald Zurbay - Jun 6, 2024 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Role: Director
Signature: /s/ Jeremy Hayden, Attorney-in-Fact for Donald Zurbay
Stock symbol: SGHT
Transactions as of: Jun 6, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/10/2024, 07:31 PM
Previous filing: Dec 7, 2023
Next filing: Jun 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGHT	Common Stock	Award	$0	+17.4K	+17.35%	$0.00	117K	Jun 6, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the closing price of the Common Stock on the grant date, June 6, 2024. The RSUs vest on the earlier of June 6, 2025 and the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
F2	Includes (i) 15,094 shares of Common Stock, (ii) 17,366 RSUs, which are subject to vesting as reported herein, and (iii) 85,000 shares of Common Stock, which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of June 6, 2024.

Content

Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the closing price of the Common Stock on the grant date, June 6, 2024. The RSUs vest on the earlier of June 6, 2025 and the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.

Includes (i) 15,094 shares of Common Stock, (ii) 17,366 RSUs, which are subject to vesting as reported herein, and (iii) 85,000 shares of Common Stock, which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of June 6, 2024.